logoTry Persana

Cambridge Cancer Genomics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Cambridge Cancer Genomics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Cambridge Cancer Genomics company logo

Cambridge Cancer Genomics (CCG.ai) is a company building software for data-driven precision oncology.

HeadquartersCambridge, United Kingdom
Team size1-10
FoundedNA

What is Cambridge Cancer Genomics? - Company Overview & Details

Cambridge Cancer Genomics is Cambridge Cancer Genomics (CCG.ai) is a company building software for data-driven precision oncology., the company is headquartered in Cambridge, United Kingdom.

Who are the Key Executives at Cambridge Cancer Genomics? - Leadership Team

Cambridge Cancer Genomics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Cambridge Cancer Genomics

CEO

Chief Technology Officer (CTO) of Cambridge Cancer Genomics

CTO

Cambridge Cancer Genomics Company Details & Key Information

Where is Cambridge Cancer Genomics located?

Cambridge Cancer Genomics is headquartered in Cambridge, United Kingdom.

How many employees does Cambridge Cancer Genomics have?

Cambridge Cancer Genomics has 1-10 employees.

Cambridge Cancer Genomics Official Website

How much funding has Cambridge Cancer Genomics raised?

Cambridge Cancer Genomics has raised undisclosed amount.

N/A
Total Funding Raised
0
Funding Rounds
N/A
Latest Round

Who are the key investors in Cambridge Cancer Genomics?

Investor Information Not Available

Detailed information about Cambridge Cancer Genomics investors is not currently available in our database.

What are Cambridge Cancer Genomics's future plans?

Future Plans Information Not Available

Detailed information about Cambridge Cancer Genomics's future plans and strategic initiatives is not currently available in our database.

What are the latest news about Cambridge Cancer Genomics?

Cambridge Cancer Genomics has 2 recent news updates covering key business developments and market activities.

Cambridge Cancer Genomics News Overview

2
Recent Articles
Active
Media Coverage
2021-07-01
Latest Update

What is Cambridge Cancer Genomics in the news for?

Cambridge Cancer Genomics is currently featured in news for DanteLabs S.r.l. acquired Ccg on Jul 10th '21. and other significant business developments.

Recent News Articles About Cambridge Cancer Genomics

Article 1
2021-07-01

DanteLabs S.r.l. acquired Ccg on Jul 10th '21.

Genomics and diagnostics company Dante Labs has acquired Cambridge Cancer Genomics.

cambridgeindependent.co.uk
Read News
Article 2
2020-02-27

Ccg partners with PRECISION-Panc.

CCG.ai partners with Precision-Panc to improve data analysis in clinical trials for pancreatic cancer.

ccg.ai
Read News

Cambridge Cancer Genomics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Cambridge Cancer Genomics including information about founders, CEO, funding history, investors, headquarters location, and company details. 6 frequently asked questions covering key information about the company.

Cambridge Cancer Genomics Questions & Answers - Company Information

Q1

What is Cambridge Cancer Genomics?

Cambridge Cancer Genomics (CCG.ai) is a company building software for data-driven precision oncology.

Q2

Where is Cambridge Cancer Genomics headquartered?

Cambridge Cancer Genomics is headquartered in Cambridge, United Kingdom.

Q3

How many employees does Cambridge Cancer Genomics have?

Cambridge Cancer Genomics has 1-10 employees.

Q4

What is Cambridge Cancer Genomics's official website?

You can visit Cambridge Cancer Genomics's official website at http://www.ccg.ai.

Q5

What does the company do?

Cambridge Cancer Genomics (CCG.ai) is a company building software for data-driven precision oncology.

Q6

Latest news?

Genomics and diagnostics company Dante Labs has acquired Cambridge Cancer Genomics. CCG.ai partners with Precision-Panc to improve data analysis in clinical trials for pancreatic cancer.

More Information About Cambridge Cancer Genomics

For additional details about Cambridge Cancer Genomics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.